Investment objective & strategy
As of Sept. 24, 2025 · prospectusObjective. Fidelity Series Intrinsic Opportunities Fund seeks capital appreciation.
Strategy. Normally investing primarily in common stocks. Investing in securities of companies that Fidelity Management & Research Company LLC (FMR) believes are undervalued in the marketplace in relation to factors such as assets, sales, earnings, growth potential, or cash flow, or in relation to securities of other companies in the same industry (stocks of these companies are often called "value" stocks). Investing in domestic and foreign issuers. Focusing investments in "value" stocks, but also may invest in companies believed to have above-average growth potential (stocks of these companies are often called "growth" stocks). Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. Normally investing primarily in common stocks. Investing in securities of companies that Fidelity Management & Research Company LLC (FMR) believes are undervalued in the marketplace in relation to factors such as assets, sales, earnings, growth potential, or cash flow, or in relation to securities of other companies in the same industry (stocks of these companies are often called "value" stocks). Investing in domestic and foreign issuers. Focusing investments in "value" stocks, but also may invest in companies believed to have above-average growth potential (stocks of these companies are often called "growth" stocks). Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.
Top holdings
As of Jan. 31, 2026 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| Fidelity Cash Central Fund | — | $78.61M | 2.66% |
| WELLS FARGO & CO | — | $46.58M | 1.58% |
| Fidelity Securities Lending Cash Central Fund | — | $37.28M | 1.26% |
| PERFORMANCE FOOD GROUP CO | — | $33.92M | 1.15% |
| ELANCO ANIMAL HEALTH INC | — | $33.37M | 1.13% |
| GILEAD SCIENCES INC | — | $32.82M | 1.11% |
| DIAMONDBACK ENERGY INC | — | $31.31M | 1.06% |
| SILGAN HOLDINGS INC | — | $30.85M | 1.04% |
| TD SYNNEX CORP | — | $29.26M | 0.99% |
| STIFEL FINANCIAL CORP | — | $28.88M | 0.98% |
Portfolio moves
Oct 31, 2025 → Jan 31, 2026How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| Fidelity Low-Priced Stock K6 Fund · FLKSX | 72% | 0.50% |
| Fidelity Low-Priced Stock Fund · FLPSX, FLPKX, FLPEX, FLPDX, FLPFX, FLPGX, FLPCX | 71% | 0.79% |
| Fidelity Fundamental Small-Mid Cap ETF · FFSM | 29% | 0.43% |
Advisers
| Firm | Role |
|---|---|
| FMR Investment Management (UK) Limited | Sub-adviser |
| Fidelity Management & Research (Japan) Limited | Sub-adviser |
| Fidelity Management & Research (Hong Kong) Limited | Sub-adviser |
| Fidelity Management & Research Company LLC | Adviser |
Footnotes
- Expense ratio as of September 24, 2025, from the fund's prospectus.
- Net assets and holdings count as of January 31, 2026, from the fund's N-PORT filing.
- Total return for calendar year 2025, before tax and after fund expenses. Computed by compounding the twelve monthly total returns the fund reported in its SEC N-PORT filings for 2025 (the latest prospectus does not yet chart this year).
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.